Location: Home
  • search
  • go
  • Relate News
  • 3/13/2024WuXi Became a Critical Partner to Biopharma Companies. They're Not Rea...
  • 3/13/2024Navigating China's Biologics Approval And Accelerated Pathways (Clinic...
  • 3/12/2024Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evo...
  • 3/12/2024BIO Faces Criticism for Involvement in Legislation Concerning China's ...
  • 3/11/2024Johnson & Johnson Completes Acquisition of Ambrx
  • 3/10/2024China Biopharma Tracker – February 2024 (PharmaNJ)
  • 3/8/2024Recent Official Changes and Executive Moves
  • 3/7/2024Lessons from China's 2023 National Negotiation of Drug Prices (NLR)
  • 3/7/2024Time To 'Cut Off' US Outbound Investment in China Biotech Firms Like B...
  • 3/6/2024US Senate Committee Approves Bill That Could Restrict Chinese Biotech
  • 3/6/2024Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...
  • 3/6/2024Shanghai's Progressive Health Insurance Initiatives: Paving the Way fo...
  • 3/6/2024China's Medical App Revolution Spearheaded by Ping An Good Doctor with...
  • 3/5/20242024 Chinese Government Work Report Highlights with Emphasis on Health...
  • 3/5/2024China Biopharma Tracker – January 2024 (PharmaNJ)
  • 3/3/2024Haihe and Taiho Enter Exclusive License Deal for Anticancer Gumarontin...
  • 3/3/2024Mabwell Out-Licenses Ex-China Rights of Rare Disease Drug to Disc Medi...
  • 3/3/2024China to Expand Basic Medical Insurance Coverage for Children
  • 3/1/2024Recent Official Changes and Executive Moves
  • 2/29/2024Review of Chinese Retail Pharmacy Market (Offline and Online) 2013-202...
  • 2/29/2024CDE Issues the Technical Guidelines for Clinical Trial of Growth Hormo...
  • 2/28/2024AstraZeneca Chooses Shanghai as Fifth Global Strategic Center, Reinfor...
  • 2/28/2024NHSA Study Affirms Generic Metformin Effectiveness in China's Bulk Buy...
  • 2/28/2024China Strengthens Healthcare Infrastructure with Over 18,000 Medical C...
  • 2/26/2024Despite Challenges, German MNCs Plans Increased Investments in China
  • 2/26/2024Mabwell Terminates Licensing Deals with Yangtze River Pharma for Two C...
  • 2/26/2024China's Online Healthcare Sector Shows Robust Growth and Evolving User...
  • 2/26/2024The Uneven Distribution of Medical Resources for Severe Diseases in Ch...
  • 2/23/2024Recent Official and Executive Moves
  • 2/22/2024Narrowly Tailored U.S. Bill Targeting Chinese Biotech Companies Sparks...
  • Page:47/371 Total number of articles:11120: [First][<<] [45] [46] [47] [48] [49] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group